ProVise Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

ProVise Management Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,634	Closed	-$458K	–	292
2024 Q3	$458K	Buy	4,634 +301	+7%	+$29.6K	0.04%	202
2024 Q2	$402K	Hold	4,333	–	–	0.03%	208
2024 Q1	$411K	Buy	4,333 +731	+20%	+$67.8K	0.04%	207
2023 Q4	$322K	Sell	3,602 -449	-11%	-$33.3K	0.03%	276
2023 Q3	$296K	Hold	4,051	–	–	0.03%	275
2023 Q2	$337K	Hold	4,051	–	–	0.03%	270
2023 Q1	$309K	Hold	4,051	–	–	0.03%	280
2022 Q4	$336K	Hold	4,051	–	–	0.03%	243
2022 Q3	$321K	Hold	4,051	–	–	0.04%	243
2022 Q2	$301K	Buy	4,051 +1,000	+33%	+$75.1K	0.03%	256
2022 Q1	$274K	Sell	3,051 -500	-14%	-$46.2K	0.03%	300
2021 Q4	$398K	Hold	3,551	–	–	0.04%	262
2021 Q3	$446K	Hold	3,551	–	–	0.04%	237
2021 Q2	$481K	Sell	3,551 -746	-17%	-$98.1K	0.05%	234
2021 Q1	$583K	Buy	4,297 +449	+12%	+$67.2K	0.06%	207
2020 Q4	$542K	Sell	3,848 -397	-9%	-$50.8K	0.06%	202
2020 Q3	$473K	Buy	4,245 +873	+26%	+$97.9K	0.06%	198
2020 Q2	$377K	Buy	3,372 +430	+15%	+$42.3K	0.05%	206
2020 Q1	$228K	Buy	+2,942	New	+$261K	0.04%	233

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

ProVise Management Group's XBI Position: Q4 2024 in Review

ProVise Management Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 4,634 shares — an estimated $458K sold.

ProVise Management Group first reported a position in XBI in Q1 2020 and held it in 19 quarters. The position peaked at $583K in Q1 2021. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

ProVise Management Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
ProVise Management Group sold 4,634 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $458K.
ProVise Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 19 quarters.
ProVise Management Group's State Street SPDR S&P Biotech ETF position peaked at $583K in Q1 2021.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on ProVise Management Group's 13F filing for Q4 2024, filed 11 Feb 2025.